Knockdown of Long Non-coding RNA LINC00467 Inhibits Glioma Cell Progression Via Modulation of E2F3 Targeted by MiR-200a

Overview

Journal Cell Cycle

Specialty Cell Biology

Date 2020 Jul 21

PMID 32684096

Citations 7

Authors

Shuzi Gao

Haixia Duan

Dezhu An

Xinfeng Yi

Jiayan Li

Changchun Liao

Affiliations

Soon will be listed here.

Abstract

Studies have found that LINC00467 is an important regulator of cancer. However, the function of LINC00467 in glioma cell is unclear. Therefore, this experimental design based on LINC00467 to explore its mechanism of action in glioma cell. RT-qPCR was used to detect the expression of LINC0046 and miR-200a in glioma cell lines. MTT assay, Edru assay and Transwell assay and flow cytometry were used to detect the effects of LINC0046 and miR-200a on PC cell proliferation, migration and apoptosis. Target gene prediction and screening, luciferase reporter assays were used to validate downstream target genes for LINC0046 and miR-200a. Western blotting was used to detect the protein expression of E2F3. The tumor changes in mice were detected by in vivo experiments in nude mice. LINC00467 was up-regulated in glioma cells. Knockdown of LINC00467 inhibited the viability, migration and invasion of glioma cells. In glioma cells, miR-200a was significantly reduced, while E2F3 was significantly rised. LINC00467 negatively regulated the expression of miR-200a in gliomas, while miR-200a negatively regulated the expression of E2F3 in gliomas. INC00467 promoted the development of glioma by inhibiting miR-200a and promoting E2F3 expression. LINC00467 may be a potential therapeutic target for gliomas.

Citing Articles

A review on the role of LINC00467 in the carcinogenesis.

Ghafouri-Fard S, Khoshbakht T, Hussen B, Taheri M, Hajiesmaeili M Cancer Cell Int. 2022; 22(1):319.

PMID: 36229833 PMC: 9563794. DOI: 10.1186/s12935-022-02724-6.

LINC00467: an oncogenic long noncoding RNA.

Chen X, Luo Q, Xiao Y, Zhu J, Zhang Y, Ding J Cancer Cell Int. 2022; 22(1):303.

PMID: 36203193 PMC: 9541002. DOI: 10.1186/s12935-022-02733-5.

Long Noncoding RNA LINC00467: Role in Various Human Cancers.

Wu D, Li R, Liu J, Zhou C, Jia R Front Genet. 2022; 13:892009.

PMID: 35719391 PMC: 9198549. DOI: 10.3389/fgene.2022.892009.

Downregulated Reprimo by LINC00467 participates in the growth and metastasis of gastric cancer.

Wu Y, Du J Bioengineered. 2022; 13(5):11893-11906.

PMID: 35549646 PMC: 9276005. DOI: 10.1080/21655979.2022.2063662.

Linc00467 promotion of gastric cancer development by directly regulating miR-7-5p expression and downstream epidermal growth factor receptor.

Deng L, Zhao H, Bai L, Xie J, Liu K, Yan F Bioengineered. 2021; 12(2):9484-9495.

PMID: 34713767 PMC: 8810099. DOI: 10.1080/21655979.2021.1996014.

References

Murthy V, Hou L, Samaras D, Kurc T, Saltz J . Center-Focusing Multi-task CNN with Injected Features for Classification of Glioma Nuclear Images. IEEE Winter Conf Appl Comput Vis. 2018; 2017:834-841. PMC: 5988234. DOI: 10.1109/WACV.2017.98. View

Xiong Y, Jia M, Yuan J, Zhang C, Zhu Y, Kuang X . STAT3‑regulated long non‑coding RNAs lnc‑7SK and lnc‑IGF2‑AS promote hepatitis C virus replication. Mol Med Rep. 2015; 12(5):6738-44. PMC: 4626162. DOI: 10.3892/mmr.2015.4278. View

. Correction to Title, Results, and Conclusion in: Down-Regulated IncRNA F630028O10Rik Contributes to Suppress Lung Cancer in Mice Through Inhibiting miR-223-3p and VEGF Signaling Pathway. Chest. 2016; 150(1):261. DOI: 10.1016/j.chest.2016.06.002. View

Amin M, Lam A . Current perspectives of mi-RNA in oesophageal adenocarcinoma: Roles in predicting carcinogenesis, progression and values in clinical management. Exp Mol Pathol. 2015; 98(3):411-8. DOI: 10.1016/j.yexmp.2015.03.002. View

Grote P, Wittler L, Hendrix D, Koch F, Wahrisch S, Beisaw A . The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell. 2013; 24(2):206-14. PMC: 4149175. DOI: 10.1016/j.devcel.2012.12.012. View

Giladi M, Munster M, Schneiderman R, Voloshin T, Porat Y, Blat R . Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells. Radiat Oncol. 2017; 12(1):206. PMC: 5747183. DOI: 10.1186/s13014-017-0941-6. View

Olsson A, Feber A, Edwards S, Te Poele R, Giddings I, Merson S . Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells. Oncogene. 2006; 26(7):1028-37. DOI: 10.1038/sj.onc.1209854. View

Pessina F, Navarria P, Cozzi L, Ascolese A, Simonelli M, Santoro A . Value of Surgical Resection in Patients with Newly Diagnosed Grade III Glioma Treated in a Multimodal Approach: Surgery, Chemotherapy and Radiotherapy. Ann Surg Oncol. 2016; 23(9):3040-6. DOI: 10.1245/s10434-016-5222-3. View

Zhang S, Xiao J, Chai Y, Du Y, Liu Z, Huang K . LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152. Dig Dis Sci. 2017; 62(11):3050-3058. DOI: 10.1007/s10620-017-4759-8. View

10.

Kiang K, Zhang X, Leung G . Long Non-Coding RNAs: The Key Players in Glioma Pathogenesis. Cancers (Basel). 2015; 7(3):1406-24. PMC: 4586776. DOI: 10.3390/cancers7030843. View

11.

Gu G, Wang L, Zhang J, Wang H, Tan T, Zhang G . MicroRNA-384 inhibits proliferation migration and invasion of glioma by targeting at CDC42. Onco Targets Ther. 2018; 11:4075-4085. PMC: 6052920. DOI: 10.2147/OTT.S166747. View

12.

Guan Y, Zhang M, Chen X, Zhang Q, Liu S, Zhang Y . Lnc RNA SNHG20 participated in proliferation, invasion, and migration of breast cancer cells via miR-495. J Cell Biochem. 2017; 119(10):7971-7981. DOI: 10.1002/jcb.26588. View

13.

Yang Y, Gao X, Zhang M, Yan S, Sun C, Xiao F . Novel Role of FBXW7 Circular RNA in Repressing Glioma Tumorigenesis. J Natl Cancer Inst. 2017; 110(3). PMC: 6019044. DOI: 10.1093/jnci/djx166. View

14.

Zhu H, Zheng T, Yu J, Zhou L, Wang L . LncRNA XIST accelerates cervical cancer progression via upregulating Fus through competitively binding with miR-200a. Biomed Pharmacother. 2018; 105:789-797. DOI: 10.1016/j.biopha.2018.05.053. View

15.

Dou Z, Lin S, Dai C, Lu Y, Tian T, Wang M . Pooling-analysis for diagnostic and prognostic value of MiRNA-100 in various cancers. Oncotarget. 2017; 8(37):62703-62715. PMC: 5617542. DOI: 10.18632/oncotarget.18697. View

16.

Chakraborty C, Sharma A, Sharma G, George Priya Doss C, Lee S . Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine. Mol Ther Nucleic Acids. 2017; 8:132-143. PMC: 5496203. DOI: 10.1016/j.omtn.2017.06.005. View

17.

Zeng Y, Wang K, Xu H, Hong Y . Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer. J Cell Biochem. 2017; 119(2):1558-1566. DOI: 10.1002/jcb.26315. View

18.

Richards E, Zhang G, Li Z, Permuth-Wey J, Challa S, Li Y . Long non-coding RNAs (LncRNA) regulated by transforming growth factor (TGF) β: LncRNA-hit-mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia. J Biol Chem. 2015; 290(11):6857-67. PMC: 4358111. DOI: 10.1074/jbc.M114.610915. View

19.

Wang B, Koh P, Winbanks C, Coughlan M, McClelland A, Watson A . miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expression. Diabetes. 2010; 60(1):280-7. PMC: 3012183. DOI: 10.2337/db10-0892. View

20.

Oberheim Bush N, Chang S, Berger M . Current and future strategies for treatment of glioma. Neurosurg Rev. 2016; 40(1):1-14. DOI: 10.1007/s10143-016-0709-8. View